ADMA Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against ADMA Biologics, Inc.

Robbins LLP, a shareholder rights law firm, has informed investors that a class action lawsuit has been filed on behalf of all investors who purchased or otherwise acquired ADMA Biologics, Inc. shares. The lawsuit alleges that the company and certain of its executives made false and misleading statements to investors regarding the company's business, operations, and financial performance. Specifically, the complaint alleges that the defendants failed to disclose material information about the company's production and supply of its products, as well as the company's reliance on a single contract with the US government for a significant portion of its revenue. As a result, investors who purchased ADMA Biologics shares may have suffered losses due to the alleged securities law violations. The lawsuit seeks to recover damages on behalf of all investors who purchased ADMA Biologics shares during the relevant period.